In melanoma cells, PD-1 can be activated by the ligand programmed death-ligand 1 (PD-L1) expressed by tumor cells, regulate downstream mammalian rapamycin signaling targets, and promote tumor growth, regardless of adaptive immunity. The gene discussed is CD274; the disease is neoplasm.